Sun Pharma to Acquire US-Based Organon for
$11.75 Billion in Major Global Deal
¨ Sun Pharmaceutical
Industries has announced an ambitious plan to acquire US-based Organon &
Co. for $11.75 billion in an all-cash deal.
¨ This will be one of the
largest overseas acquisitions ever made by an Indian company.
¨ The acquisition is
expected to strengthen India’s presence in the global pharmaceutical industry.
¨ Under the agreement, Sun
Pharma will purchase all outstanding shares of Organon at $14 per share.
¨
The deal has been
approved by the boards of both companies.
¨
It will be completed
after receiving regulatory and shareholder approvals.
¨
The transaction is
expected to close by early 2027.
¨
The announcement
triggered a strong market reaction.
¨
Sun Pharma shares rose by
more than 7% following the news.
